Grow Therapy Secures $150M In Series D Funding Led By TCV And Goldman Sachs

Grow Therapy, a mental health platform based in New York City, raised $150 million in Series D funding, increasing its total funding to $328 million and valuing the company at $3 billion. The funding round was led by TCV and Goldman Sachs Alternatives, with additional participation from BCI, Menlo Ventures, Sequoia, SignalFire, and Transformation Capital.

Summary of transaction details:

• Deal Type: Series D
• Transaction Amount: $150,000,000
• Total Funding: $328,000,000
• Valuation: $3,000,000,000
• Founded by: Jake Cooper, Manoj Kanagaraj & Alan Ni
• Headquarters: New York City
• Notable Investors: TCV, Goldman Sachs Alternatives, BCI, Menlo Ventures, Sequoia Capital, SignalFire, Transformation Capital

Grow Therapy connects patients with therapists and psychiatrists covered by insurance, supporting a network of 26,000 providers and serving 220 million Americans. CEO and co-founder Jake Cooper leads the initiative to enhance AI tools and health system integrations as part of their operational expansion.